Immunotherapy Combined with Large Fractions of Radiotherapy: Stereotactic Radiosurgery for Brain Metastases—Implications for Intraoperative Radiotherapy after Resection
Brain metastases (BM) affect approximately a third of all cancer patients with systemic disease. Treatment options include surgery, whole-brain radiotherapy, or stereotactic radiosurgery (SRS) while chemotherapy has only limited activity. In cases where patients undergo resection before irradiation,...
Main Authors: | Carsten Herskind, Frederik Wenz, Frank A. Giordano |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2017-07-01
|
Series: | Frontiers in Oncology |
Subjects: | |
Online Access: | http://journal.frontiersin.org/article/10.3389/fonc.2017.00147/full |
Similar Items
-
Role of Radiosurgery/Stereotactic Radiotherapy in Oligometastatic Disease: Brain Oligometastases
by: Rosario Mazzola, et al.
Published: (2019-04-01) -
The Judicious Use of Stereotactic Radiosurgery and Hypofractionated Stereotactic Radiotherapy in the Management of Large Brain Metastases
by: Tyler Gutschenritter, et al.
Published: (2021-12-01) -
Stereotactic Radiosurgery/Radiotherapy: A Historical Review
by: Mansoureh Nabavi, et al.
Published: (2014-04-01) -
Improving the therapeutic ratio of stereotactic radiosurgery and radiotherapy
by: Andisheh, Bahram
Published: (2012) -
Whole brain radiotherapy versus stereotactic radiosurgery for 4–10 brain metastases: a phase III randomised multicentre trial
by: Jaap D. Zindler, et al.
Published: (2017-07-01)